TTY Biopharm Co Ltd (台灣東洋藥品) chairman Lin Chuan (林全) yesterday refuted rumors that the company had engaged in insider trading ahead of last month’s announcement that it had won conditional rights to market Bio-NTech SE’s COVID-19 vaccine in Taiwan.
Lawmakers on Monday said they suspected that the firm was involved in insider trading, as 2,414 TTY units were traded on the Taipei Exchange on Oct. 12, surging 6.6 times from an average daily trading volume of 365 units in September.
TTY said that it had secured authorization to market the vaccines after the market closed on the same day.
Photo: CNA
The firm’s share price spiked from NT$69.5 to NT$84.3 on Oct. 15, when a total of 30,108 units were traded, before gradually falling to NT$82.2 on Monday last week, with a total 10,725 units traded, one day before TTY said it had terminated its bid to gain Bio-NTech’s authorization to market the vaccine.
The transactions must have been done by someone with insider information, Chinese Nationalist Party (KMT) Legislator William Tseng (曾銘宗) said on Monday.
“I never conducted any insider trading as I despise the behavior. I would welcome any investigation,” Lin told a news conference in Taipei.
“However, there indeed was a chance that someone conducted the insider trading, as the trading volume on Oct. 12 was too high to be normal,” Lin said.
TTY noticed the abnormal trading activity late on Oct. 12 and ran a preliminary investigation before notifying the exchange on Oct. 15, general manager Robbin Shih (施俊良) told a media briefing.
In addition to TTY employees, some officials at the Centers for Disease Control (CDC), Bio-NTech staff and local agents of China-based Shanghai Fosun Pharmaceutical Co (上海復星醫藥) were involved in the negotiations and knew TTY’s intention to introduce the vaccines, Shih said.
“I highly doubt that it was outside people who conducted the illegal trading, but I would not know who they were. I hope that prosecutors can get to the bottom of it soon,” Lin said.
TTY’s move to abandon the bid to market the vaccine in Taiwan gained attention, as the Bio-NTech and Pfizer Inc-developed vaccine had shown 90 percent effectiveness in preventing COVID-19, prompting speculation that TTY had failed to reach an agreement due to political concerns.
Lin said that TTY stopped trying to acquire the rights as the number of vaccines the CDC intends to purchase was much less than TTY’s expectations, which made the negotiations between TTY and Bio-NTech difficult.
The US dollar was trading at NT$29.7 at 10am today on the Taipei Foreign Exchange, as the New Taiwan dollar gained NT$1.364 from the previous close last week. The NT dollar continued to rise today, after surging 3.07 percent on Friday. After opening at NT$30.91, the NT dollar gained more than NT$1 in just 15 minutes, briefly passing the NT$30 mark. Before the US Department of the Treasury's semi-annual currency report came out, expectations that the NT dollar would keep rising were already building. The NT dollar on Friday closed at NT$31.064, up by NT$0.953 — a 3.07 percent single-day gain. Today,
‘SHORT TERM’: The local currency would likely remain strong in the near term, driven by anticipated US trade pressure, capital inflows and expectations of a US Fed rate cut The US dollar is expected to fall below NT$30 in the near term, as traders anticipate increased pressure from Washington for Taiwan to allow the New Taiwan dollar to appreciate, Cathay United Bank (國泰世華銀行) chief economist Lin Chi-chao (林啟超) said. Following a sharp drop in the greenback against the NT dollar on Friday, Lin told the Central News Agency that the local currency is likely to remain strong in the short term, driven in part by market psychology surrounding anticipated US policy pressure. On Friday, the US dollar fell NT$0.953, or 3.07 percent, closing at NT$31.064 — its lowest level since Jan.
Hong Kong authorities ramped up sales of the local dollar as the greenback’s slide threatened the foreign-exchange peg. The Hong Kong Monetary Authority (HKMA) sold a record HK$60.5 billion (US$7.8 billion) of the city’s currency, according to an alert sent on its Bloomberg page yesterday in Asia, after it tested the upper end of its trading band. That added to the HK$56.1 billion of sales versus the greenback since Friday. The rapid intervention signals efforts from the city’s authorities to limit the local currency’s moves within its HK$7.75 to HK$7.85 per US dollar trading band. Heavy sales of the local dollar by
The Financial Supervisory Commission (FSC) yesterday met with some of the nation’s largest insurance companies as a skyrocketing New Taiwan dollar piles pressure on their hundreds of billions of dollars in US bond investments. The commission has asked some life insurance firms, among the biggest Asian holders of US debt, to discuss how the rapidly strengthening NT dollar has impacted their operations, people familiar with the matter said. The meeting took place as the NT dollar jumped as much as 5 percent yesterday, its biggest intraday gain in more than three decades. The local currency surged as exporters rushed to
RSS